Literature DB >> 21869841

NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia.

T H Terwey, A Vega-Ruiz, P G Hemmati, P Martus, E Dietz, P le Coutre, G Massenkeil, B Dörken, R Arnold.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21869841     DOI： 10.1038/leu.2011.230

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT.

Authors:  A Ruggeri; G Sanz; H Bittencourt; J Sanz; A Rambaldi; F Volt; I Yakoub-Agha; J M Ribera; L Mannone; J Sierra; M Mohty; C Solano; S Nabhan; W Arcese; E Gluckman; M Labopin; V Rocha
Journal:  Leukemia       Date:  2013-09-05       Impact factor: 11.528

2.  Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.

Authors:  A Ruggeri; M Labopin; G Sanz; S Piemontese; W Arcese; A Bacigalupo; D Blaise; A Bosi; H Huang; D Karakasis; Y Koc; M Michallet; A Picardi; J Sanz; S Santarone; H Sengelov; J Sierra; L Vincent; F Volt; A Nagler; E Gluckman; F Ciceri; V Rocha; M Mohty
Journal:  Leukemia       Date:  2015-04-17       Impact factor: 11.528

3.  Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

Authors:  Shernan G Holtan; Nandita Khera; John E Levine; Xiaoyu Chai; Barry Storer; Hien D Liu; Yoshihiro Inamoto; George L Chen; Sebastian Mayer; Mukta Arora; Jeanne Palmer; Mary E D Flowers; Corey S Cutler; Alexander Lukez; Sally Arai; Aleksandr Lazaryan; Laura F Newell; Christa Krupski; Madan H Jagasia; Iskra Pusic; William Wood; Anne S Renteria; Gregory Yanik; William J Hogan; Elizabeth Hexner; Francis Ayuk; Ernst Holler; Phandee Watanaboonyongcharoen; Yvonne A Efebera; James L M Ferrara; Angela Panoskaltsis-Mortari; Daniel Weisdorf; Stephanie J Lee; Joseph Pidala
Journal:  Blood       Date:  2016-09-13       Impact factor: 22.113

4.  Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia.

Authors:  Ali Bazarbachi; Myriam Labopin; Didier Blaise; Edouard Forcade; Gerard Socié; Ana Berceanu; Emanuele Angelucci; Claude Eric Bulabois; Nicolaus Kröger; Alessandro Rambaldi; Patrice Ceballos; Stephan Mielke; Jean El Cheikh; Ibrahim Yakoub-Agha; Bipin Savani; Alexandros Spyridonidis; Arnon Nagler; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2020-10-06       Impact factor: 5.483

Review 5.  Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis.

Authors:  S Fadilah Abdul Wahid; Nor-Azimah Ismail; Mohd-Razif Mohd-Idris; Fariza Wan Jamaluddin; NorRafeah Tumian; Ernie Yap Sze-Wei; Norasiah Muhammad; Ming Lai Nai
Journal:  Stem Cells Dev       Date:  2014-09-17       Impact factor: 3.272

6.  Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.

Authors:  Eolia Brissot; Myriam Labopin; Matthias Stelljes; Gerhard Ehninger; Rainer Schwerdtfeger; Jürgen Finke; Hans-Jochem Kolb; Arnold Ganser; Kerstin Schäfer-Eckart; Axel R Zander; Donald Bunjes; Stephan Mielke; Wolfgang A Bethge; Noël Milpied; Peter Kalhs; Igor-Woflgang Blau; Nicolaus Kröger; Antonin Vitek; Martin Gramatzki; Ernst Holler; Christoph Schmid; Jordi Esteve; Mohamad Mohty; Arnon Nagler
Journal:  J Hematol Oncol       Date:  2017-06-24       Impact factor: 17.388

7.  Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party.

Authors:  Mohamad Mohty; Arnon Nagler; Eolia Brissot; Myriam Labopin; Domenico Russo; Sonja Martin; Christoph Schmid; Bertram Glass; Ron Ram; Zubeyde Nur Ozkurt; Jakob Passweg; Joan Hendrik Veelken; Donald Bunjes; Jane Apperley; Sebastian Giebel
Journal:  Bone Marrow Transplant       Date:  2020-03-17       Impact factor: 5.483

8.  Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine.

Authors:  Federica Giannotti; Myriam Labopin; Roni Shouval; Jaime Sanz; William Arcese; Emanuele Angelucci; Jorge Sierra; Josep-Maria Ribera Santasusana; Stella Santarone; Bruno Benedetto; Alessandro Rambaldi; Riccardo Saccardi; Didier Blaise; Michele Angelo Carella; Vanderson Rocha; Frederic Baron; Mohamad Mohty; Annalisa Ruggeri; Arnon Nagler
Journal:  J Hematol Oncol       Date:  2018-08-30       Impact factor: 17.388

9.  Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.

Authors:  Rama Al Hamed; Myriam Labopin; Etienne Daguindau; Riitta Niittyvuopio; Anne Huynh; Gerard Socié; Micha Srour; Jean Henri Bourhis; Nicolaus Kröger; Eleni Tholouli; Goda Choi; Xavier Poiré; Hans Martin; Marie-Thérèse Rubio; Pavel Jindra; Didier Blaise; Dietrich Beelen; Hélène Labussière-Wallet; Arnon Nagler; Ali Bazarbachi; Mohamad Mohty
Journal:  Cancer Med       Date:  2022-01-20       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.